Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

ClinicalTrials.gov ID: NCT00137345

Public ClinicalTrials.gov record NCT00137345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 10:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine When Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if one drug is superior to another with regard to safety and the preservation of renal function after a kidney transplant.

Study identification

NCT ID
NCT00137345
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
500 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2005 (Type not available)
Primary completion
Aug 2006 (Actual)
Completion
Aug 2006 (Actual)
Last update posted
Feb 8, 2013

2005 – 2006

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
21
Facility City State ZIP Site status
Not listed San Diego California 92123 —
Not listed San Francisco California 94143 —
Not listed Denver Colorado 80262 —
Not listed New Haven Connecticut 06520 —
Not listed Gainesville Florida 32610 —
Not listed Tampa Florida 33606 —
Not listed Atlanta Georgia 30309 —
Not listed Chicago Illinois 60612-3824 —
Not listed Portland Maine 04102 —
Not listed Springfield Massachusetts 01199 —
Not listed Detroit Michigan 48202 —
Not listed New York New York 10029 —
Not listed Charlotte North Carolina 28203 —
Not listed Durham North Carolina 27710 —
Not listed Cleveland Ohio 44106 —
Not listed Cleveland Ohio 44195 —
Not listed Toledo Ohio 43614 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Philadelphia Pennsylvania 19129 —
Not listed Providence Rhode Island — —
Not listed Charleston South Carolina 29425 —
Not listed Dallas Texas 75246 —
Not listed Houston Texas 77225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00137345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2013 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00137345 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →